Regeneron Pharmaceuticals
REGN
#273
Rank
โ‚น7.492 T
Marketcap
โ‚น70,872
Share price
1.18%
Change (1 day)
9.60%
Change (1 year)

Earnings for Regeneron Pharmaceuticals (REGN)

Earnings in 2025 (TTM): โ‚น457.86 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are โ‚น14.34 Billion. , an increase over its 2024 earnings that were of โ‚น440.61 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Regeneron Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น482.16 B9.43%
2024 โ‚น440.61 B13.83%
2023 โ‚น387.09 B-13.57%
2022 โ‚น447.88 B-47.9%
2021 โ‚น859.65 B144.75%
2020 โ‚น351.24 B56.86%
2019 โ‚น223.91 B-4.87%
2018 โ‚น235.38 B22.86%
2017 โ‚น191.59 B56.3%
2016 โ‚น122.58 B8.55%
2015 โ‚น112.92 B54.53%
2014 โ‚น73.08 B11.14%
2013 โ‚น65.75 B72.13%
2012 โ‚น38.20 B-285.93%
2011 -โ‚น20.55 Billion121.73%
2010 -โ‚น9.27 Billion37.18%
2009 -โ‚น6.76 Billion-14.6%
2008 -โ‚น7.92 Billion-25.02%
2007 -โ‚น10.56 Billion6.32%
2006 -โ‚น9.93 Billion-186.52%
2005 โ‚น11.46 B2103.7%
2004 โ‚น0.52 B-105.66%
2003 -โ‚น9.2 Billion-18.18%
2002 -โ‚น11.25 Billion42.33%
2001 -โ‚น7.9 Billion129.35%
2000 -โ‚น3.45 Billion51.87%
1999 -โ‚น2.27 Billion92.19%
1998 -โ‚น1.18 Billion66.23%
1997 -โ‚น0.71 Billion-55.49%
1996 -โ‚น1.6 Billion103.53%
1995 -โ‚น0.79 Billion-70.89%
1994 -โ‚น2.7 Billion-26.08%
1993 -โ‚น3.65 Billion114.67%
1992 -โ‚น1.7 Billion196.77%
1991 -โ‚น0.58 Billion87.88%
1990 -โ‚น0.31 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.986 T 519.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.507 T 212.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚น759.93 B 57.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น838.86 B 73.98%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น175.51 B-63.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น12.01 B-97.51%๐Ÿ‡บ๐Ÿ‡ธ USA